AIM
AIM ImmunoTech

34,411
Mkt Cap
$7.48M
Volume
390,445.00
52W High
$36.00
52W Low
$2.33
PE Ratio
-0.11
AIM Fundamentals
Price
$2.76
Prev Close
$2.55
Open
$2.68
50D MA
$2.60
Beta
0.57
Avg. Volume
146,701.90
EPS (Annual)
-$30.92
P/B
-0.32
Rev/Employee
$7,391.30
Loading...
Loading...
News
all
press releases
Zacks.com featured highlights include The Honest Company, Dutch, AIM ImmunoTech, Masimo and Cognizant Technology Solutions
HNST, BROS, AIM, MASI, and CTSH are spotlighted as top-ranked stocks with rising P/E ratios and strong earnings momentum.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Bet On 5 Top-Ranked Stocks With Rising P/E
Tap these five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks are The Honest Company, Dutch Bros, AIM ImmunoTech, Masimo and Cognizant Technology Solutions.
Zacks·4d ago
News Placeholder
All You Need to Know About AIM ImmunoTech (AIM) Rating Upgrade to Buy
AIM ImmunoTech (AIM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·16d ago
News Placeholder
FibroGen (FGEN) Reports Q2 Loss, Lags Revenue Estimates
FibroGen (FGEN) delivered earnings and revenue surprises of -50.22% and -53.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week
New trial data, a reverse split, and financing moves triggered a spike in retail chatter for these biotech stocks in the week ending Feb. 28, 2025.
Stocktwits·8mo ago

Latest AIM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.